518 related articles for article (PubMed ID: 35958856)
21. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
22. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
[TBL] [Abstract][Full Text] [Related]
23. Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Koyuncu CF; Nag R; Lu C; Corredor G; Viswanathan VS; Sandulache VC; Fu P; Yang K; Pan Q; Zhang Z; Xu J; Chute DJ; Thorstad WL; Faraji F; Bishop JA; Mehrad M; Castro PD; Sikora AG; Thompson LDR; Chernock RD; Lang Kuhs KA; Wasman JK; Luo JR; Adelstein DJ; Koyfman SA; Lewis JS; Madabhushi A
Cancer; 2022 Nov; 128(21):3831-3842. PubMed ID: 36066461
[TBL] [Abstract][Full Text] [Related]
24. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
[TBL] [Abstract][Full Text] [Related]
26. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
[TBL] [Abstract][Full Text] [Related]
27. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
28. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of reduced- versus standard-dose radiotherapy on survival and radiation-associated toxicity in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review protocol.
Lee TJ; Krishnan G; Ooi EH; Barker TH
JBI Evid Synth; 2022 Apr; 20(4):1135-1141. PubMed ID: 34698708
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.
Kelly JR; Park HS; An Y; Contessa JN; Yarbrough WG; Burtness BA; Decker R; Husain Z
JAMA Oncol; 2017 Aug; 3(8):1107-1111. PubMed ID: 28056116
[TBL] [Abstract][Full Text] [Related]
31. Association of HPV status with survival after surgical salvage of oropharyngeal cancers.
Patel TR; Lee S; Tajudeen BA; Stenson K; Bhayani M; Al-Khudari S
Am J Otolaryngol; 2022; 43(4):103491. PubMed ID: 35567838
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
[TBL] [Abstract][Full Text] [Related]
33. Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer.
Park YM; Lim JY; Koh YW; Choi EC; Kim SH
Head Neck; 2023 Sep; 45(9):2369-2376. PubMed ID: 37489048
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
[TBL] [Abstract][Full Text] [Related]
35. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
Hu Q; Li F; Yang K
PeerJ; 2024; 12():e17391. PubMed ID: 38784388
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
Justesen MM; Jakobsen KK; Bendtsen SK; Garset-Zamani M; Mordhorst C; Carlander AF; Gothelf AB; Grønhøj C; von Buchwald C
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680237
[TBL] [Abstract][Full Text] [Related]
37. Functional Genetic Variants in TGFβ1 and TGFβR1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma.
Niu Z; Sun P; Liu H; Wei P; Wu J; Huang Z; Gross ND; Shete S; Wei Q; Zafereo ME; Calin GA; Li G
Clin Cancer Res; 2023 Aug; 29(16):3081-3091. PubMed ID: 37327315
[TBL] [Abstract][Full Text] [Related]
38. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
[TBL] [Abstract][Full Text] [Related]
39. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
[TBL] [Abstract][Full Text] [Related]
40. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]